Suppr超能文献

胰肾联合移植术后切口疝:来自布达佩斯的单中心经验

Incisional hernia after simultaneous pancreas kidney tranplantation: a single-center experience from Budapest.

作者信息

Piros L, Máthé Zs, Földes K, Langer R M

机构信息

Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary.

出版信息

Transplant Proc. 2011 May;43(4):1303-5. doi: 10.1016/j.transproceed.2011.03.090.

Abstract

INTRODUCTION

The occurrence of postoperative incisional hernia is more frequent after simultaneous pancreas-kidney transplantation compared with other transplanted parenchymal organs. These complications are especially dangerous in this patient population, because they can compromise the survival of the transplanted organ.

METHODS

We performed a retrospective review of a series of adult patients with incisional herniae after 23 consecutive simultaneous pancreas-kidney transplantations between January 2004 and June 2010 seeking to identify risk factors. All 23 patients had a body mass index (BMI) of <25. All surgeons used a similar technique, including a median incision with an intraperitoneal approach, and systemic venous and enteric drainage methods and a layered fascial closure. All combined pancreas-kidney transplant recipients received induction with thymoglobulin and maintenance therapy with sirolimus, reduced-dose cyclosporine and corticosteroids.

RESULTS

An incisional hernia repair was performed in 8/23 patients (34.8%). Four reoperations were required in this group (50%), due to hemoperitoneum (n=2), intra-abdominal abscess (n=1), and venous thrombosis (n=1). The mean elapsed time between transplantation and hernioplasty was 24.5 months (range, 8-51). There was no significant difference in age, gender, BMI, dialysis modality, or operative time among affected compared with the other members of the group.

CONCLUSION

Despite lack of obesity we observed a relatively higher rate of postoperative herniase, possibly owing to the side effects of a thymoglobulin-sirolimus combination.

摘要

引言

与其他实质器官移植相比,胰肾联合移植术后切口疝的发生率更高。这些并发症在该患者群体中尤其危险,因为它们可能危及移植器官的存活。

方法

我们对2004年1月至2010年6月期间连续23例胰肾联合移植术后发生切口疝的成年患者进行了回顾性研究,以确定危险因素。所有23例患者的体重指数(BMI)均<25。所有外科医生均采用类似技术,包括经腹腔正中切口、全身静脉和肠道引流方法以及分层筋膜缝合。所有胰肾联合移植受者均接受了胸腺球蛋白诱导治疗,并采用西罗莫司、小剂量环孢素和皮质类固醇进行维持治疗。

结果

23例患者中有8例(34.8%)进行了切口疝修补术。该组中有4例(50%)需要再次手术,原因是腹腔内出血(n = 2)、腹腔内脓肿(n = 1)和静脉血栓形成(n = 1)。移植与疝修补术之间的平均间隔时间为24.5个月(范围为8 - 51个月)。与该组其他成员相比,受影响患者在年龄、性别、BMI、透析方式或手术时间方面无显著差异。

结论

尽管患者不存在肥胖情况,但我们观察到术后疝的发生率相对较高,这可能归因于胸腺球蛋白 - 西罗莫司联合使用的副作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验